Company: BIVIW
Filing Date: 2025-07-11
Form Type: S-1/A
Source: 0001520138-25-000205
Chunk: 227

Company: BIOVIE INC.
Filing Date: 2025-07-11
Form: S-1/A
Chunk 227
---
 per share and/or
pre-funded warrants to purchase shares of Common Stock, at a public offering price to the Investors of $15.30 per pre-funded warrant,
together with warrants to purchase up to 196,080 shares of Common Stock.

In connection to the September 23 Offering, the
Company issued the Placement Agent II Warrants, exercisable to purchase 9,804 shares of Common Stock, representing 5% of the September
23 Securities purchased at the closing of the September 23 Offering, for an aggregate purchase price of $100.00, at an exercise price
of $19.125 per share, which is equal to 125% of the September 23 Share Offering Price. The Placement Agent II Warrants are exercisable
from 180 days following the date of issuance in accordance with the 5110(g)(8)(A) of FINRA and will expire five years following the date
of issuance.

The holders of the Placement Agent II Warrants
may exercise the Placement Agent II Warrants by making a cash payment equal to the exercise price multiplied by the quantity of shares.
The holders of the Placement Agent II Warrants may also exercise the Placement Agent II Warrants on a cashless or “net issuance”
basis by receiving a net number of shares calculated pursuant to the formula set forth in the Placement Agent II Warrants. The Placement
Agent II Warrants are subject to anti-dilution adjustments for stock dividends, stock splits, and reverse stock splits. Pursuant to the
terms of the Placement Agent II Warrants, the holders of the Placement Agent II Warrants are entitled to piggyback registration rights
if the Company proposes to file a new registration statement under the Securities Act, subject to certain limitations.

Private Placement I Warrants and Placement Agent III Warrants Issued in Connection with Offering on October 21, 2024

On October 21, 2024, the Company entered into
the October 21, 2024 PAA with ThinkEquity LLC, as the placement agent, in connection with the issuance and sale directly to the October
21 Investors of up to 444,300 shares of the Common Stock, at a public offering price to the October 21 Investors of $15.00 per share.

In a concurrent private placement, pursuant to
the October 21, 2024 PAA, to issue to the October 21 Investors the unregistered Private Placement I Warrants to purchase 444,300 shares
of Common Stock, with each